genomics Archives

Best in Biotech 13 Sep 2022

The five hottest private biotech companies in India

India is brimming with biotech companies and a young and skilled workforce. Here’s a quick glance at the private healthcare biotechs in India that captured investors’ imaginations in the last couple of years. India has historically been known for its large IT, pharmaceutical and vaccine manufacturing sectors, but is also a force to be reckoned […]

September 13, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 6 Sep 2022

Finnish researchers use machine learning to unlock clinical cancer samples’ genomic code

A new paper from the University of Helsinki, published in Nature Communications, suggests a method for accurately analyzing genomics data in archival cancer biopsies. The tool uses machine learning methods to correct damaged DNA and unveil the true mutation processes in tumor samples. This helps to unlock medicine values in millions of archival cancer samples. […]

September 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 29 Aug 2022

Malaysian Genomics and Ajlan to explore MENA biopharma opportunities

Malaysian Genomics Resource Centre Berhad, a genomics and biopharmaceutical company, has signed a memorandum of understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. Ajlan, based in Riyadh, Saudi Arabia, is part of a multinational conglomerate established in 1979 with extensive global private […]

August 29, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 26 Aug 2022

Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics

This week it’s another four interview podcast, and the introduction of a new feature. Our guests are Ilya Pharma CEO and co-founder Evelina Vågesjö and chief financial officer Oskar Lund; Miguel Martín-Álvarez, postdoctoral fellow in the cancer science unit at IRB Barcelona; Hubert Chen, head of clinical development at Krystal Biotech; and Ivan Liachko, CEO […]

August 26, 2022

News and Trends 25 Jul 2022

Replay launches with $55M to reprogram biology by writing and delivering big DNA

Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay, which is based in San Diego, Cal., and London, U.K., […]

July 25, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 14 Jul 2022

Telo Genomics launches clinical study of drug resistance test for multiple myeloma

Canadian biotech company Telo Genomics Corp. has started the processing of clinical samples to evaluate its TeloView platform to identify multiple myeloma (MM) patients at high-risk of developing treatment resistance. The study is the second being carried out in collaboration with the Mayo Clinic to evaluate the company’s prognostic technology to address multiple unmet clinical […]

July 14, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 28 Jun 2022

Time Partners closes £30M venture fund to back life sciences startups

Time Partners Limited has announced the final closing of its first advised fund, Time Boost Capital I LP, a £30 million ($36.6 million) genomics venture fund to provide match funding to startups graduating from Illumina Accelerator Cambridge, UK. Since opening in July 2020, Illumina Accelerator Cambridge has launched 13 startups focused on harnessing genomics applications […]

June 28, 2022 - 2 minutesmins - By Jim Cornall

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us